MorrisKletzelMD
Pediatric Hematology & Oncology • Highland Park, ILProfessor in Pediatrics, Northwestern University Medical School
Dr. Kletzel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
324 Leonard wood s apt 201
Highland Park, IL 60035Phone+1 773-456-3341- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1980- University of Texas Health Science Center at HoustonResidency, Pediatrics, 1978 - 1979
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1975 - 1978
Universidad Nacional Autonoma de MexicoClass of 1972
Certifications & Licensure
IL State Medical License 1991 - 2023
AR State Medical License 1985 - 2000- American Board of Pediatrics Pediatrics
Clinical Trials
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) Start of enrollment: 2000 Mar 10
- Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors Start of enrollment: 1999 Apr 01
- WT1 for the Detection of Minimal Residual Disease Start of enrollment: 1999 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsAssociation Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablat...Bognàr, T., Bartelink, I., Egberts, T., Rademaker, C., Versluys, A., Slatter, M., Kletzel, M., Nath, C., Cuvelier, G., Savic, R., Dvorak, C., Long-Boyle, J., Cowan, M....> ;Transplantation and Cellular Therapy. 2022 Apr 1
- 4 citationsReduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-ri...Jenna Rossoff, David A. Jacobsohn, Morris Kletzel, Reggie E. Duerst, William T. Tse, Jennifer Schneiderman, Sonali Chaudhury> ;Pediatric Blood & Cancer. 2021 May 22
- 14 citationsVeno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.Tal Schechter, Evelio Perez-Albuerne, Tiffany F. Lin, Meredith S. Irwin, Mohammed Sh. Essa, Ami V. Desai, Haydar Frangoul, Gregory A. Yanik, L. Lee Dupuis, David A. Ja...> ;Bone Marrow Transplantation. 2020 Mar 1
- Join now to see all
Journal Articles
- Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in NeuroblastomaGregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature
Abstracts/Posters
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) StudyMorris Kletzel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) StudyMorris Kletzel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
Hospital Affiliations
Northwestern Memorial HospitalChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
